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2290risks for all-cause mortality and
CVD events, respectively (9).
Unlike other important risk
factors, CRF is not routinely
measured. It requires trained
personnel to administer an exer-
cise test using specialized equip-
ment. With the publication of
nonexercise algorithms, it is now
feasible to estimate CRF with
reasonable accuracy using health
indicators typically available in
ﬁeld and healthcare settings.Over 2 decades ago, we published the ﬁrst equations (10),
and many others have been developed more recently
(11–15). Although they provide accurate estimates at the
population level, these models were developed with cross-
sectional data. Furthermore, age was included as a linear
term, and recent longitudinal data have demonstrated that
CRF declines nonlinearly with aging (16). To address this
issue, we recently developed new longitudinal algorithms
that estimate CRF changes associated with aging (17). The
error estimates ranged from 1.41 to 1.69 METs (17).
Whether estimated CRF can predict health risk is yet to
be determined. To the best of our knowledge, only Stama-
takis et al. (18) have explored the association between es-
timated CRF and mortality. After a mean follow-up of
9 years, a higher level of estimated CRF was associated
with lower risks for mortality from all causes and from CVD
(18). Interestingly, the discriminative ability (as determined
by c statistic) of estimated CRF was better than that of
any of its modiﬁable components (body mass index [BMI],
self-reported physical activity, and resting heart rate
[RHR]) (18).
Given the underutilization of ﬁtness testing and the po-
tential of estimated CRF as demonstrated by Stamatakis
et al. (18), the purpose of the present analyses was to
examine the capacity of our new longitudinal CRF algo-
rithms to predict incident CVD and disease-speciﬁc mor-
tality. This study will add to the previous one (18) by
comparing risk-predictive capacity with measured CRF and
by adding nonfatal major CVD events, in a large established
database with long-term follow-up.Methods
Study population. The ACLS (Aerobics Center Longi-
tudinal Study) is a prospective, observational study in adult
men and women who have undergone preventive medical
evaluations at the Cooper Clinic (Dallas, Texas) (1). Par-
ticipants were unpaid volunteers, mostly of non-Hispanic
white race, well-educated, and worked in executive or
professional positions. All participants provided written
informed consent and the study protocol was approved
annually.Inclusion criteria for the present analysis were: no history
of or existing CVD (myocardial infarction [MI] or stroke)
or cancer at baseline; achieving 85% or more of the patient’s
age-predicted maximal heart rate (220 – age) during treadmill
exercise testing; BMI 18.5 kg/m2; 1 year of follow-up;
and complete data on CRF, mortality outcomes, covariates,
and all parameters included in the CRF algorithms (17).
These criteria resulted in 43,356 patients (21% women) aged
20 to 84 years who had undergone a baseline examination
between 1974 and 2002.
Baseline examination. The clinical examinations were
completed after an overnight fast. Height and weight were
measured on a physician’s scale and stadiometer, and BMI
was calculated. Waist circumference (WC) was measured
level with the umbilicus. Resting systolic and diastolic blood
pressures were measured with a mercury sphygmomanometer
using standard auscultation methods (19). Blood chemistries
were analyzed with automated bioassays in the Cooper Clinic
laboratory. Concentrations of total cholesterol and fasting
plasma glucose were measured in accordance with the standards
of the Centers for Disease Control and Prevention’s Lipid
Standardization Program (20).
PHYSICAL ACTIVITY. A formerly validated questionnaire was
used to assess self-reported leisure-time physical activity
(21). A 5-level physical activity index was created (17):
no regular activity (level 0); some regular activity such as
bicycling, swimming, racquet sports, and other strenuous
sports, but not walking or jogging (level 1); walking or
jogging <10 miles per week (level 2); walking or jogging
10 to 20 miles per week (level 3); and walking or jogging
>20 miles per week (level 4). Walking and jogging were
used as the basis of physical activity because they were
the most common activities in this population. A second
physical activity index was deﬁned as inactive (levels 0 to 2)
or active (level 3 or 4) to match as closely as possible the
consensus recommendation of 150 min per week of aerobic
activity (22).
MEASURED CRF. Measured CRF was quantiﬁed as the
duration of a symptom-limited maximal treadmill exercise
test using a modiﬁed Balke protocol (1,23). Patients were
encouraged to give maximal effort, and the test endpoint was
volitional exhaustion or termination by the physician for
medical reasons. We calculated METs from the ﬁnal
treadmill speed and grade (24). Exercise treadmill duration
on this protocol is highly correlated (r  0.92) with
measured peak oxygen uptake (6,7). Participants were clas-
siﬁed into lower, middle, and upper groups on the basis
of age- (20 to <40, 40 to <50, 50 to <60, or 60 years) and
sex-speciﬁc thirds of METs distribution.
ESTIMATED CRF. Four different sex-speciﬁc algorithms
were created to estimate CRF, on the basis of age, BMI
(or percent body fat), WC, RHR, physical activity index (in
2 or 5 levels), and smoking status, as previously described
and validated (17). For a higher applicability, the present
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(rather than body fat) and physical activity in 2 levels
(rather than 5):
omen : Estimated CRFðMETsÞ
¼ 14:7873þ Age 0:1159 Age2  0:0017
 BMI 0:1534 WC 0:0085 RHR  0:0364
þ Active 0:5987 Smoker 0:2994
or
Men : Estimated CRFðMETsÞ
¼ 21:2870þ Age 0:1654 Age2  0:0023
 BMI 0:2318 WC 0:0337 RHR  0:0390
þ Active 0:6351 Smoker 0:4263Þ
where active ¼ 1 if the participant was classiﬁed as physi-
cally active or 0 if inactive; and smoker ¼ 1 if current smoker
or 0 if not. Once the algorithms were implemented, par-
ticipants were classiﬁed into lower, middle, and upper
groups on the basis of age- (20 to <40, 40 to <50, 50
to <60, or 60 years) and sex-speciﬁc thirds of MET
distribution.
Assessment of outcomes. Participants were followed up
from the baseline examination until the date of death or
December 31, 2003. Mortality surveillance was on the basis
of the National Death Index. The underlying cause of death
was determined from the National Death Index report or by
a nosologist’s review of the ofﬁcial death certiﬁcate. CVD-
related mortality was deﬁned by International Classiﬁca-
tion of Diseases-Ninth Revision (ICD-9) codes 390 to
449.9 before 1999 and Tenth Revision (ICD-10) codes I00
to I78 during 1999–2003 (25).
Incidence of nonfatal CVD events was ascertained in a
subsample of 18,095 patients (20% women) from responses
to mail-back health surveys in 1982, 1999, and 2004. The
aggregate survey response rate across all survey periods in
the ACLS was 65% to 75% (26). Baseline health histories
and clinical measures were similar between respondents
and nonrespondents and between early and late re-
spondents (27).
Nonfatal CVD endpoints were deﬁned as diagnosis by a
physician of MI, stroke, or the need for a coronary revascu-
larization procedure. In participants reporting multiple
events, the ﬁrst event was used for analysis. In a random
sample of these endpoints, we applied a standard deﬁnition
for deﬁning and adjudicating MI, revascularization, and
stroke (28). The percentages of agreement between reported
events and participants’medical records were 88%, 100%, and
89% for MI, revascularization, and stroke, respectively (26).
Statistical analysis. Participants’ baseline characteristics were
summarized on the basis of sex and estimated CRF level, using
analysis of the variance and chi-square tests. We used Cox
proportional hazards regression to estimate hazard ratios (HRs)and 95% conﬁdence intervals (CIs) according to CRF levels
(both measured and estimated). Multivariate analyses included
these covariates: age (in years), examination year, alcohol intake
(dichotomized as heavy drinker or not:>14 drinks per week in
men and >7 drinks per week in women [29]), presence or
absence of hypercholesterolemia (total cholesterol 240 mg/dl
or previous physician’s diagnosis), hypertension (resting
blood pressure 140/90 mm Hg or previous physician’s
diagnosis), diabetes mellitus (fasting blood glucose
126 mg/dl, previous physician’s diagnosis, or use of insulin),
abnormal resting or exercise electrocardiography, and/or
parental history of CVD. Sensitivity analyses compared the
performance of the algorithms with 5 and 2 levels of physical
activity and excluded intermediate covariates that could be on
the causal pathway (hypercholesterolemia, hypertension, dia-
betes). Cumulative hazard plots grouped by exposure categories
suggested no appreciable violations of the proportional hazards
assumption.
To compare the risk-predictive capacity of measured and
estimated CRF, we constructed receiver operating charac-
teristic curves with corresponding areas under the curve
(AUCs). The AUC (also known as c statistic) is a function of
both the sensitivity and speciﬁcity of the model across all
of its values, and it represents the ability of the score
to discriminate future cases from noncases (30). The risk-
predictive capacity of estimated CRF was also compared
with its modiﬁable constituent components (BMI, WC,
RHR, and physical activity). We used existing methods (18)
to develop a continuous clustered score. After z-score con-
version of each variable (z ¼ [Value – Mean]/standard de-
viation [SD]), the 4 z-scores were summed, and the sum was
divided by 4 to compile a score with units of SD. The
continuous variable for physical activity (originally active or
inactive) was calculated as MET –minutes per week (22). As
it is protective, the z-score from physical activity was
multiplied by –1. Smoking status was not included in this
analysis as it was deﬁned as a dichotomous variable (current
smoker or not).
Finally, we calculated the net reclassiﬁcation improvement
(NRI) for all-cause mortality between estimated and
measured CRF. On the basis of subsequent observed cases,
this index integrates proportions of appropriate and inap-
propriate reclassiﬁcations between 2 risk-prediction models
(30). NRI was calculated as (18,31):
NRI¼
h
PðupjcaseÞPðdownjcaseÞþPðdownjnoncaseÞPðupjnoncaseÞ
i
100
where P is the proportion of participants moving up or down
in terms of predicted risk category.
The NRI was statistically examined by an asymptotictest (31).
Data analyses were performed using SPSS version 20.0
(IBM SPSS Statistics, IBM Corporation, Armonk, New
York), and all p values are 2-sided with an alpha level
of 0.05.
Table 2 Hazard Ratios for Disease-Speciﬁc Mortality and Nonfatal CVD, by CRF Level, in Men (n ¼ 34,211)
Measured CRF Estimated CRF
n/N
Hazard Ratio (95% CI)
n/N
Hazard Ratio (95% CI)
Model 1* Model 2y Model 1* Model 2y
All-cause mortality
Lower 793/11,329 1 (Ref) 1 (Ref) 642/11,402 1 (Ref) 1 (Ref)
Middle 524/12,164 0.64 (0.57–0.71) 0.68 (0.61–0.76) 557/11,405 0.74 (0.66–0.82) 0.79 (0.70–0.88)
Upper 401/10,718 0.49 (0.44–0.55) 0.56 (0.49–0.63) 519/11,404 0.59 (0.53–0.67) 0.67 (0.59–0.75)
p for linear trend <0.001 <0.001 <0.001 <0.001
Per 1-MET increase 0.84 (0.83–0.86) 0.87 (0.85–0.89) 0.82 (0.79–0.84) 0.85 (0.82–0.88)
CVD-related mortality
Lower 304/11,329 1 (Ref) 1 (Ref) 249/11,402 1 (Ref) 1 (Ref)
Middle 164/12,164 0.52 (0.43–0.63) 0.60 (0.49–0.72) 170/11,405 0.59 (0.48–0.71) 0.66 (0.54–0.80)
Upper 109/10,718 0.34 (0.27–0.43) 0.45 (0.36–0.57) 158/11,404 0.47 (0.38–0.57) 0.59 (0.48–0.73)
p for linear trend <0.001 <0.001 <0.001 <0.001
Per 1-MET increase 0.78 (0.75–0.81) 0.83 (0.79–0.86) 0.76 (0.72–0.80) 0.81 (0.77–0.86)
Nonfatal CVD
Lower 353/4,335 1 (Ref) 1 (Ref) 309/4,048 1 (Ref) 1 (Ref)
Middle 346/5,140 0.72 (0.62–0.83) 0.80 (0.69–0.93) 327/4,902 0.76 (0.65–0.89) 0.84 (0.71–0.98)
Upper 278/4,985 0.47 (0.40–0.55) 0.57 (0.48–0.67) 341/5,510 0.56 (0.48–0.65) 0.66 (0.56–0.78)
p for linear trend <0.001 <0.001 <0.001 <0.001
Per 1-MET increase 0.87 (0.84–0.89) 0.90 (0.87–0.93) 0.84 (0.80–0.88) 0.89 (0.85–0.93)
*Adjusted for age and examination year. yAdjusted for age, examination year, alcohol intake (heavy drinker or not), hypercholesterolemia, hypertension, diabetes, abnormal resting or exercise ECG,
and parental history of CVD (present or not for each).
CI ¼ conﬁdence interval; other abbreviations as in Table 1.
Table 1
Baseline Characteristics of the Study Participants, by Sex and Estimated CRF Level, Aerobics Center Longitudinal Study
(1974–2002)
Characteristic
Men (n ¼ 34,211) Women (n ¼ 9,145)
Lower
CRF Level
(n ¼ 11,402)
Middle
CRF Level
(n ¼ 11,405)
Upper
CRF Level
(n ¼ 11,404)
Lower
CRF Level
(n ¼ 3,048)
Middle
CRF Level
(n ¼ 3,049)
Upper
CRF Level
(n ¼ 3,048)
Clinical
Age, yrs 44.9 (10.0) 44.5 (9.7) 44.0 (9.5)y 44.9 (11.0) 44.5 (10.3) 44.0 (10.7)*
Body mass index, kg/m2 30.2 (3.6) 25.9 (1.7) 23.5 (1.7)y 27.1 (4.5) 22.5 (2.0) 20.8 (1.5)y
Waist circumference, cm 103.8 (9.4) 92.4 (5.7) 84.9 (6.3)y 82.3 (11.2) 71.4 (7.0) 67.5 (5.3)y
Resting heart rate, bpm 66.6 (10.5) 60.4 (8.8) 53.6 (8.4)y 71.0 (10.3) 64.6 (7.8) 56.7 (7.5)y
Treadmill time, min 15.1 (3.9) 18.3 (3.9) 22.0 (4.3)y 11.2 (3.6) 13.7 (3.8) 16.5 (4.4)y
Blood pressure, mm Hg
Systolic 125.2 (13.4) 120.3 (12.7) 118.0 (12.9)y 117.7 (14.9) 112.1 (14.1) 109.6 (13.8)y
Diastolic 84.7 (9.6) 80.8 (9.0) 78.2 (8.8)y 79.2 (9.6) 75.7 (9.1) 73.9 (9.1)y
Laboratory
CRF, METs
Measured 10.3 (1.8) 11.8 (1.9) 13.6 (2.3)y 8.5 (1.7) 9.7 (1.8) 10.9 (2.1)y
Estimated 10.7 (1.2) 12.4 (0.7) 13.8 (0.8)y 9.0 (0.9) 10.1 (0.5) 10.9 (0.6)y
Total cholesterol, mg/dl 215.6 (41.3) 210.0 (43.2) 199.4 (44.5)y 205.7 (39.5) 198.1 (45.5) 192.9 (34.7)y
Glucose, mg/dl 104.2 (22.1) 99.4 (15.2) 97.7 (86.9)y 96.5 (15.4) 96.3 (167.5) 91.9 (11.0)
History
Physically active 645 (5.7) 1,505 (13.2) 5,157 (45.2)y 143 (4.7) 314 (10.3) 1,224 (40.2)y
Current smoker 2,766 (24.3) 1,983 (17.4) 915 (8.0)y 338 (11.1) 301 (9.9) 148 (4.9)y
Heavy drinker 986 (8.6) 981 (8.6) 797 (7.0)y 297 (9.7) 334 (11.0) 361 (11.8)*
Hypercholesterolemia 4,044 (35.5) 3,238 (28.4) 2,281 (20.0)y 888 (29.1) 616 (20.2) 468 (15.4)y
Diabetes mellitus 866 (7.6) 404 (3.5) 249 (2.2)y 169 (5.5) 101 (3.3) 85 (2.8)y
Hypertension 5,168 (45.3) 3,120 (27.4) 2,105 (18.5)y 799 (26.2) 440 (14.4) 342 (11.2)y
Abnormal ECG 957 (8.4) 804 (7.0) 714 (6.3)y 270 (8.9) 216 (7.1) 158 (5.2)y
Parental history of CVD 3,152 (27.6) 3,144 (27.6) 3,133 (27.5) 824 (27.0) 842 (27.6) 800 (26.2)
Values are mean (SD) or n (%). Analysis of the variance or chi-square test were used to test the differences between groups in each sex: *p < 0.05; yp < 0.001.
bpm ¼ beats/min; CRF ¼ cardiorespiratory ﬁtness; CVD ¼ cardiovascular disease; ECG ¼ electrocardiography; MET ¼ metabolic equivalent.
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Descriptive characteristics of the study population are pre-
sented in Table 1. Men and women with higher levels of
estimated CRF had lower BMI, WC, RHR, total choles-
terol and glucose concentrations (except in women), and
systolic and diastolic blood pressures. Participants with
higher levels of estimated CRF were more likely to be
physically active and less likely to be smokers and heavy
drinkers (except in women) and to have hypercholesterole-
mia, diabetes mellitus, hypertension, or an abnormal
electrocardiography.
The median (25th to 75th percentiles) follow-up period
for mortality was 14.5 (5.7 to 20.1) years. A total of 1,934
participants died, 627 from CVD. For incidence of nonfatal
CVD events, the follow-up period was 7.7 (2.9 to 16.5)
years and 1,049 cases were registered. Tables 2 and 3 show
HRs (95% CI) by CRF levels. In men, both measured CRF
and estimated CRF were inversely associated with the risks
for all-cause mortality (HR per 1-MET increase, measured
CRF: 0.87 [95% CI: 0.85 to 0.89]; estimated CRF: 0.85
[95% CI: 0.82 to 0.88]), CVD-related mortality (measured
CRF: 0.83 [95% CI: 0.79 to 0.86]; estimated CRF: 0.81
[95% CI: 0.77 to 0.86]), and nonfatal CVD events
(measured CRF: 0.90 [95% CI: 0.87 to 0.93]; estimated
CRF: 0.89 [95% CI: 0.85 to 0.93]), after adjustments for
potential confounders (Table 2). In women, both measured
CRF and estimated CRF were inversely associated with
risks for all-cause mortality (measured CRF: 0.91 [95% CI:
0.85 to 0.99]; estimated CRF: 0.87 [95% CI: 0.75 to 0.99])
and nonfatal CVD events (measured CRF: 0.77 [95% CI:Table 3 Hazard Ratios for Disease-Speciﬁc Mortality and Nonfatal C
Measured CRF
n/N
Hazard Ratio (95% CI)
Model 1* Mod
All-cause mortality
Lower 109/3,143 1 (Ref) 1 (Re
Middle 66/3,076 0.92 (0.68–1.25) 0.91 (0.
Upper 41/2,926 0.75 (0.52–1.07) 0.74 (0.
p for linear trend 0.281 0.2
Per 1-MET increase 0.92 (0.85–0.99) 0.91 (0.
CVD-related mortality
Lower 25/3,143 1 (Ref) 1 (Re
Middle 16/3,076 1.05 (0.56–1.97) 1.08 (0.
Upper 9/2,926 0.80 (0.37–1.72) 0.89 (0.
p for linear trend 0.793 0.9
Per 1-MET increase 0.92 (0.78–1.09) 0.95 (0.
Nonfatal CVD
Lower 42/1,206 1 (Ref) 1 (Re
Middle 15/1,175 0.35 (0.19–0.63) 0.36 (0.
Upper 15/1,254 0.35 (0.19–0.63) 0.38 (0.
p for linear trend < 0.001 < 0
Per 1-MET increase 0.75 (0.65–0.87) 0.77 (0.
*Adjusted for age and examination year. yAdjusted for age, examination year, alcohol intake (heavy
and parental history of CVD (present or not for each).
Abbreviations as in Tables 1 and 2.0.67 to 0.90]; estimated CRF: 0.76 [95% CI: 0.58 to 0.99])
(Table 3). Excluding hypercholesterolemia, hypertension
and diabetes as confounders slightly strengthened some of
these results (data not shown).
Table 4 presents the discrimination statistics of measured
CRF and estimated CRF. The c statistic values (AUC) were
slightly higher for measured CRF than for estimated CRF.
In both cases, the discriminative ability was always higher
for CVD-related mortality than for any other outcome. In
general, c statistic values were higher in women than in men.
The lowest c statistic value was 0.61 (estimated CRF
discriminating nonfatal CVD events in men) and the highest
was 0.74 (measured CRF discriminating CVD-related
mortality in women). As can be observed in Table 5, the
discriminative ability of estimated CRF was greater than
that of any of its modiﬁable components, separately or
together, in men and women, and for all outcomes.
Finally, Table 6 compares the reclassiﬁcation statistics for
all-cause mortality between both CRF methods. Compared
to estimated CRF, measured CRF reclassiﬁed correctly
12.7% of men and 20.8% of women who died (i.e., they were
reclassiﬁed to a higher-risk category). The overall NRI
values were 12.3% in men (p < 0.05) and 19.8% in women
(p < 0.001).
All of the analyses (Tables 2 to 6) were repeated using
the algorithms with the 5-level physical activity variable.
The results were virtually the same, with a risk-predictive
capacity and discriminative ability similar to those pro-
vided by the 2-level physical activity algorithms (data not
shown).VD, by CRF Level, in Women (n ¼ 9,145)
Estimated CRF
n/N
Hazard Ratio (95% CI)
el 2y Model 1* Model 2y
f) 74/3,048 1 (Ref) 1 (Ref)
67–1.24) 77/3,049 0.83 (0.60–1.14) 0.82 (0.59–1.13)
52–1.07) 65/3,048 0.68 (0.49–0.95) 0.67 (0.48–0.94)
75 0.079 0.068
85–0.99) 0.87 (0.75–0.99) 0.87 (0.75–0.99)
f) 21/3,048 1 (Ref) 1 (Ref)
57–2.04) 15/3,049 0.63 (0.32–1.22) 0.70 (0.35–1.37)
41–1.94) 14/3,048 0.58 (0.29–1.17) 0.65 (0.32–1.31)
05 0.230 0.410
81–1.13) 0.83 (0.63–1.08) 0.84 (0.64–1.12)
f) 27/1,024 1 (Ref) 1 (Ref)
20–0.66) 27/1,239 0.64 (0.38–1.11) 0.73 (0.42–1.26)
21–0.69) 18/1,372 0.34 (0.19–0.63) 0.38 (0.20–0.70)
.001 0.003 0.008
67–0.90) 0.69 (0.54–0.89) 0.76 (0.58–0.99)
drinker or not), hypercholesterolemia, hypertension, diabetes, abnormal resting or exercise ECG,
Table 4 Discrimination Statistics of Measured and Estimated CRF for Disease-Speciﬁc Mortality and Nonfatal CVD
Measured CRF Estimated CRF
All-Cause Mortality CVD-Related Mortality Nonfatal CVD All-Cause Mortality CVD-Related Mortality Nonfatal CVD
Men (n ¼ 34,211)
Cases 1,718 577 977* 1,718 577 977*
AUC (95% CI)y 0.67 (0.66–0.69) 0.72 (0.70–0.74) 0.62 (0.60–0.64) 0.63 (0.61–0.64) 0.68 (0.66–0.70) 0.61 (0.59–0.62)
Sensitivityz 0.46 0.53 0.36 0.37 0.43 0.32
Speciﬁcityx 0.68 0.67 0.70 0.67 0.67 0.72
Women (n ¼ 9,145)
Cases 216 50 72* 216 50 72*
AUC (95% CI)y 0.70 (0.66–0.73) 0.74 (0.68–0.80) 0.71 (0.64–0.77) 0.64 (0.60–0.68) 0.73 (0.66–0.81) 0.68 (0.62–0.74)
Sensitivityz 0.50 0.50 0.58 0.34 0.42 0.38
Speciﬁcityx 0.66 0.66 0.67 0.67 0.67 0.72
*Subsample of 14,460 men and 3,635 women. yCalculated from inverted CRF (as it is protective). zThe proportion of cases captured by lower CRF group (highest risk). xThe proportion of noncases
captured by combined middle and upper CRF groups.
AUC ¼ area under the curve; other abbreviations as in Table 1.
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The purpose of the present study was to investigate the
association of estimated CRF, on the basis of longitudinal
algorithms, with disease-speciﬁc mortality and nonfatal
CVD events in middle-aged men and women. Previous
studies had shown that these (17) and other nonexercise
equations (10–13,15) estimate CRF with reasonable accu-
racy at the population level. Now we show that estimated
CRF, calculated from typically available health indicators,
signiﬁcantly predicted future risk for nonfatal CVD events
as well as all-cause and CVD-related mortality, after ad-
justment for standard risk factors. However, these algo-
rithms can still be reﬁned for a better risk-prediction
performance, as measured CRF presented a better discrim-
inative capacity (c statistic) and reclassiﬁed correctly a sig-
niﬁcant proportion of cases (NRI).
Clinicians have long been aware that patients capable of
high levels of physical exertion have a better prognosis than
do those with limited exercise capacity. Data from the
ACLS and other epidemiologic studies indicate that pa-
tients with low CRF are much more likely to develop hy-
pertension (32), diabetes (32,33), and metabolic syndrome
(32,34) and to have higher rates of death due to CVD
(3,35), cancer (36), and all causes (1,3,37). Many experts
have recommended CRF testing in asymptomatic andTable 5
AUCs (95% CI) for the Modiﬁable Constituent Components
and for Estimated CRF
Men (n ¼ 34,211)
All-Cause Mortality CVD-Related Mortality Nonfa
Body mass index 0.49 (0.48–0.51) 0.53 (0.51–0.55) 0.53 (0
Waist circumference 0.53 (0.52–0.55) 0.58 (0.55–0.60) 0.56 (0
Resting heart rate 0.55 (0.53–0.56) 0.56 (0.54–0.59) 0.52 (0
Physical activityy 0.58 (0.57–0.59) 0.57 (0.55–0.60) 0.54 (0
Clustered score 0.55 (0.54–0.57) 0.58 (0.56–0.61) 0.56 (0
Estimated CRFy 0.63 (0.61–0.64) 0.68 (0.66–0.70) 0.61 (0
*Subsample of 14,460 men and 3,635 women. yCalculated from inverted physical activity and CRF (as
Abbreviations as in Tables 1 and 5.symptomatic men and women of all ages (38), and the
American Heart Association recently highlighted the need
for a national CRF registry (39). The present algorithms are
a practical alternative for an estimate of CRF and are a
useful tool for identifying persons at risk. The potential
clinical implications are substantial, as this method could
be applied to electronic medical record systems and easily
determined in patients in clinical practice or in health
maintenance plans.
The risk reduction per 1-MET increase observed in our
study is consistent with previous ﬁndings using measured
CRF (9), and with those from the only study so far inves-
tigating estimated CRF and mortality (18). Similar to our
results, those studies suggested a 10% to 20% risk reduction
per 1-MET increase, with the effect being slightly higher
for CVD events than for all-cause mortality (9,18). Our
ﬁndings indicate a similar protective trend in men and
women, although in women there was no association with
CVD-related mortality, and the linear trend for all-cause
mortality did not reach statistical signiﬁcance. The smaller
number of cases in women likely decreased the statistical
power, as suggested in previous ACLS studies (26). In the
Lipid Research Clinics study (40), CRF predicted CVD-
related mortality risk in women and men, whereas in the
Framingham Heart Study, CRF was signiﬁcantly associ-
ated with coronary heart disease events in men but not inof the Nonexercise CRF Algorithms (Separately and Clustered)
Women (n ¼ 9,145)
tal CVD* All-Cause Mortality CVD-Related Mortality Nonfatal CVD*
.51–0.55) 0.50 (0.47–0.54) 0.51 (0.43–0.58) 0.56 (0.50–0.63)
.55–0.58) 0.53 (0.49–0.57) 0.56 (0.49–0.63) 0.59 (0.52–0.65)
.50–0.54) 0.52 (0.48–0.56) 0.62 (0.55–0.69) 0.56 (0.49–0.62)
.52–0.55) 0.61 (0.58–0.65) 0.61 (0.54–0.69) 0.59 (0.53–0.65)
.54–0.57) 0.56 (0.53–0.60) 0.61 (0.54–0.69) 0.62 (0.56–0.68)
.59–0.62) 0.64 (0.60–0.68) 0.73 (0.66–0.81) 0.68 (0.62–0.74)
they are protective).
Table 6
Reclassiﬁcation of the Predicted Risk for All-Cause Mortality in Men and Women on the Basis of
Estimated CRF Versus Measured CRF
Estimated CRF
Measured CRF
Reclassiﬁed as
Higher Risk
Reclassiﬁed as
Lower Risk
Net Correctly
Reclassiﬁed (%)Lower (Highest Risk) Middle Upper
Men*
Cases (n ¼ 1,718) 468 250 12.7
Lower (highest risk) 487 132 23
Middle 232 230 95
Upper 74 162 283
Noncases (n ¼ 32,493) 6,886 6,760 –0.4
Lower (highest risk) 6,758 3,406 596
Middle 2,964 5,126 2,758
Upper 814 3,108 6,963
Womeny
Cases (n ¼ 216) 81 36 20.8
Lower (highest risk) 54 16 4
Middle 37 24 16
Upper 18 26 21
Noncases (n ¼ 8,929) 2,099 2,007 –1.0
Lower (highest risk) 1,794 874 306
Middle 868 1277 827
Upper 372 859 1,752
*Net reclassiﬁcation improvement: 12.3% (p < 0.05). yNet Reclassiﬁcation improvement: 19.8% (p < 0.001).
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our models for CVD-related mortality (from 0.68 to
0.74) was close to that observed for the Framingham risk
score and other similar prediction models (0.75 to 0.80),
on the basis of the combination of multiple independent
risk markers (30). The c-statistic values reported by Sta-
matakis et al. (18) for CVD deaths were also comparable
(0.73 to 0.75).
The potential mechanisms for the protective role of
estimated CRF could be the same as those attributed to
measured CRF, achieved in most cases through healthy
life-style habits: lower levels of adiposity, blood pressure,
and chronic inﬂammation; higher insulin sensitivity and
glycemic control; more favorable lipid proﬁle; enhanced
endothelial function; improved cardiac autonomic regula-
tion; and preserved functional capacity and cognitive ability
during aging, among others (22). In our study, those par-
ticipants with higher levels of estimated CRF had lower
BMI, WC, RHR, cholesterol and glucose concentrations,
and systolic and diastolic blood pressures and were more
likely to be physically active and less likely to be smokers
and to have hypercholesterolemia, diabetes mellitus, or
hypertension.
Strengths and limitations. Notable features make this a
robust set of ﬁndings: the possibility of comparing the risk-
predictive capacity between measured and estimated CRF;
the large set of major outcomes studied (all-cause mortal-
ity, CVD-related mortality, and incidence of nonfatal
CVD events); the large sample size and long follow-up;
and the broad range of potential confounders taken into
account. However, measured CRF was not directly
assessed by gas analysis, but was indirectly calculated fromtreadmill speed and grade. Although cardiopulmonary
exercise testing is considered the gold standard, both
assessed and calculated METs from exercise tests have
been shown to be among the strongest predictors of
adverse events in a prognostic model (9). The lack of in-
formation on diet and medication use/adherence may have
introduced some residual confounding. The most heavily
weighted variable (physical activity) was self-reported,
although any objective alternative would be less practical.
And ﬁnally, participants were mostly of non-Hispanic
white ethnicity, well-educated, and with professional po-
sitions; we do not know how well our algorithms would
predict health risk in other populations. Cross-validation
studies are needed to investigate the generalizability of
these results by testing the algorithms’ predictive capacity
in other cohorts.
Conclusions
Our longitudinal algorithms utilize information routinely
collected to obtain an estimate of CRF that provides a valid
indication of health status. Although the method can still be
reﬁned, estimated CRF signiﬁcantly predicted the risk for
nonfatal CVD events and all-cause and disease-speciﬁc mor-
tality. In addition to identifying people at risk, this method
can potentially be utilized to provide more appropriate ex-
ercise recommendations that reﬂect initial CRF levels.
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